top of page

Biotech & AI Expert | Business Leader | Public Servant

Wesite Page Pic.png

Guadalupe
Hayes-Mota

Biotech & AI Expert.
Business Leader.
Public Servant.

Story

Story

Born in Mexico with a rare and debilitating bleeding disorder, Guadalupe nearly died at twelve because of limited access to medicines. One night, his appendix burst, and he began bleeding internally, requiring emergency surgery. In search of better medication to stop the bleeding, Guadalupe was rushed to a hospital eight hours away. He bled so severely during the surgery that his heart stopped beating, and the doctors declared him clinically dead. But against all odds, Guadalupe survived.

After his recovery, his family and he migrated to the U.S., searching for better healthcare for him. The transition was difficult: his parents arrived in California with little money or education, and Guadalupe spoke no English. Navigating the health care system as an immigrant and not knowing the language was a challenge. Accessing treatment and services for his disease was practically impossible at first. The nearest specialist was one hr and a half away. Thankfully, he gained access to care and treatment with help from the Hemophilia Association chapter in the area. Driven by his experiences, Guadalupe made it his mission to fight for justice and equity in the healthcare system.

Guadalupe Hayes-Mota

Guadalupe Hayes-Mota

Play Video

Video: Guadalupe speaks about growing up with hemophilia in Mexico without medicines.

Professional Experience

Experience

Mission..............................

Guadalupe Hayes-Mota envisions a world where medical care is a fundamental right, not a privilege. Drawing strength from his life experiences on the margins, he is a steadfast advocate for justice and equity. Guadalupe is a driving force for change and innovation in healthcare, spanning biopharmaceuticals, nonprofits, and cutting-edge technology.

Guadalupe Hayes-Mota Picture in Memorial Drive

Professional Experience.........

Guadalupe Hayes-Mota is a seasoned healthcare expert and serial entrepreneur. Currently, he serves as the CEO & Co-Founder of a stealth-mode AI healthcare startup while teaching as a Senior Lecturer at MIT.

Previously, Guadalupe founded and served as CEO of Healr Solutions, a pioneering tech company addressing critical challenges in the biopharmaceutical supply chain, impacting 43 countries. The company was acquired by major investors. He also held leadership roles as Senior Vice President and Chief Supply Chain Officer at global pharmaceutical giants, including Ultragenyx, Biogen, Amgen, and GSK, where he ensured medicine delivery to 2.3 billion people in 113 countries.

At UCLA Health, under Guadalupe’s leadership, it became the largest free healthcare provider in the U.S., serving 30,000 underserved individuals. His contributions to the Affordable Care Act at the RAND Corporation helped expand healthcare access to 20 million Americans. Additionally, he collaborated on groundbreaking drug research at MIT with Moderna’s founder, Professor Bob Langer.

Public Service & Boards.........

Guadalupe was appointed by President Joe Biden and Health and Human Services Secretary Xavier Becerra to the NIH Cures Acceleration Network Review Board, where he advises on strategies to accelerate treatment development globally. He also served on the Massachusetts Rare Disease Advisory Council, shaping state policies on rare diseases under Governor Charlie Baker.

He is an AI Expert Advisor to the European Commission and the World Economic Forum, guiding global AI policy. Guadalupe also serves as an AI and Biotech Expert Advisor to OpenAI, the creators of ChatGPT.

In addition, he holds leadership roles on boards and advisory councils, including AI 2030, Blue Clay Health, MIT Alumni Association, Fenway Health, and Save One Life. He also serves on Sanofi’s Advisory Board and contributes to Forbes, Fast Company, and Harvard Business Review advisory councils.

Thought Leadership .........

Guadalupe Hayes-Mota lecturing at MIT a class on bioengineering and medicine

As a recognized thought leader in healthcare and AI, Guadalupe’s work has been featured in Forbes, Inc., Fast Company, MarketWatch, Boston Globe, MIT Technology Review, and other prominent outlets. He has delivered keynotes at institutions like the National Academy of Engineering, MIT, Harvard, and UPenn, and he has testified before the U.S. Congress on critical healthcare issues.

Guadalupe is an active writer for Forbes and Fast Company, sharing insights on biotechnology, AI, and business innovation. His recently published memoir, Rising Through the Dust, offers an intimate look at his journey, blending personal narratives with professional experiences that highlight his profound impact on global healthcare and biotechnology.

Education............................

Guadalupe Hayes-Mota delivering a keynote speech at MIT

BS in Chemistry and BS in Literature – MIT
MS in AI Engineering Systems – MIT
MBA – MIT
Master of Public Administration – Harvard University
Doctor of Engineering in AI (abd) – George Washington University

Honors................................

6 Powerful LGBTQ+ Executives - Business Insider
US Young Engineering Leader - National Academy of Engineering
John F. Kennedy Fellowship - Harvard University
Notable Alum - MIT
100 Top Leaders in the Life Science Industry - PharmaVoice
40 under 40 - Boston Business Journal
Healthcare Executive of the Year - Los Angeles Business Journal

Community Leadership

Public Service

NIH
Cures Acceleration Network
Board Member

Appointed by the U.S. Health and Human Services Secretary to advise the NIH, federal agencies, and stakeholders on advancing and accelerating the development of high-need cures.

Guadalupe Hayes-Mota appointed to the Massachusetts Rare Disease Advisory Council

Rare Disease Advisory Council
Council Member

Appointed by Governor Baker to provide advice to the Governor, Senate, House of Representatives, and Department of Public Health on how to address rare disease policy and actions in Massachusetts.

European Commission.png

European Commission
AI Expert Advisor

Provided guidance to the Commission, EU member states, and stakeholders on fostering the development and adoption of trustworthy AI technologies across Europe.

World Economic Forum
AI Expert Advisor

Advises on the integration of AI in healthcare, public policy, and business, contributing to global discussions on responsible AI deployment.

Teaching

Teaching

Teacher/ Mentor of the Next Generation of STEM Entrepreneurs Leaders

Guadalupe Hayes-Mota teaching at MIT

Guadalupe Hayes-Mota is a Senior Lecturer at MIT

Senior Lecturer and Practitioner in Residence - MIT

Guadalupe Hayes-Mota teaches ethics of biopharmaceuticals, global operations, leadership in healthcare organizations, and medical egineering.

guadalupe hayes-mota teaching_edited.jpg

Press

In The News

Press

Guadalupe Hayes-Mota published in the Boston Globe

Guadalupe Hayes-Mota presenting results of Healr Solutions at the National Academy of Engineering

Guadalupe Hayes-Mota published in the MIT Technology Review

Guadalupe Hayes-Mota written in Rare Revolution Magazine

Guadalupe Hayes-Mota recognized as 40 under 40 by the Boston Business Journal

Guadalupe Hayes-Mota named Pharmavoice 100 Most Inspiring Leader

Publications

Publications

AI Is Rapidly Transforming Drug Discovery

by Guadalupe Hayes-Mota

The biopharmaceutical industry stands on the cusp of a revolution, with artificial intelligence (AI) emerging as a transformative force in drug development. AI's ability to reduce the time and cost of bringing new drugs to market is not just a promise; it is becoming a reality. In this article, we delve into the ways AI is reshaping drug development, analyzing the mechanics behind each method and their future potential and then ranking them on their overall impact on the industry.

Five Areas Where AI Is Revolutionizing The Biopharmaceutical Industry

by Guadalupe Hayes-Mota

With the increasing amount of available data, AI and machine learning have emerged as crucial tools for biopharmaceutical companies looking to remain competitive in the market. These tools are helping researchers speed up drug discovery, improve the clinical trial design and further personalize patient treatment.

Here are five areas where I see AI and machine learning changing the biopharmaceutical industry.

Seven Ways to Overcome Obstacles to Using AI in Healthcare

by Guadalupe Hayes-Mota

Systemic hurdles such as data privacy concerns, the absence of standardized data protocols, regulatory complexities, and ethical dilemmas are compounded by an inherent resistance to change within the healthcare profession. These barriers underscore the urgent need for transformative action from all stakeholders to fully harness AI’s capabilities.

Shaping A Responsible AI-Powered Future In Life Science

by Guadalupe Hayes-Mota

The unprecedented power of artificial intelligence (AI) is transforming the life sciences industry, opening doors to groundbreaking drug discoveries, innovative treatments and the promise of personalized medicine. As we harness AI's potential, addressing the ethical challenges that arise is imperative. This article outlines a new, robust ethical framework to ensure that AI serves humanity's best interests.

7 Strategies For Biopharmaceutical Company Fundraising

by Guadalupe Hayes-Mota

Launching a biopharmaceutical company requires groundbreaking scientific research and substantial financial resources. At the same time, securing funding may seem daunting, but various strategies and ideas can greatly enhance your chances of successfully raising capital.

As a founder and CEO of a startup and someone who has worked in fundraising, here are some valuable tips and innovative approaches to fundraising for biopharmaceutical startups.

15 Tips For Identifying And Addressing Operational Inefficiencies

by Guadalupe Hayes-Mota

Every organization faces operational inefficiencies that can impede productivity, hinder growth and waste resources. As a leader, it's your responsibility to identify these inefficiencies and streamline processes to make your organization more efficient and effective. However, identifying the biggest operational inefficiencies can be a challenge, especially if you don't know where to look.

Using AI for Public Impact

by Guadalupe Hayes-Mota

As a leader in healthcare innovation with a stealth-mode AI company developing pain medications, my interest in Dr. Saghafian’s work was piqued by the potential of AI to revolutionize healthcare and the business landscape. Here, I present five significant insights from Dr. Saghafian, which I gathered from an interview with him on AI’s transformative power in healthcare, public policy, and business.

Three Ways to Provide Better Access to Medicine Globally

by Guadalupe Hayes-Mota

The global healthcare landscape is undergoing a significant transformation. Driven by the need to make healthcare more equitable, especially in low- and middle-income countries (LMICs), three innovative strategies are leading the charge: enhancing local pharmaceutical production, forming strategic partnerships, and pooling purchasing power. These initiatives are not just reshaping access to medicines but laying the groundwork for a more balanced and accessible global health system.

Speaking Arrangement

Lavender Graduation Keynote Banner.jpg

Keynote Speaker (MIT Lavender Graduation Keynote): Guadalupe celebrates the achievements of the LGBT+ Graduates.

Keynote Speaker (Harvard Center for Public Leadership): Guadalupe talks about how curiosity saved his life by developing new drugs

Keynote Presentation (Clinical Trials Summit): Guadalupe talks about how to manage Clinical Global Supply Chains during COVID-19 times.

Speaking Engagements

Keynote Speaker (National Academy of Engineering): Guadalupe explores the technology needed to create connected supply chain in the biopharmaceutical world.

PIA Puerto Rico.jpg

Keynote Speaker (Pharmaceutical Industry Association of Puerto Rico): Guadalupe discusses how to create access to medicines to patients worlwide

Guadalupe Hayes-Mota presentation of the Industrial Internet of Things Insights at a conference

Presentation (Biomanufacturing and Cell and Gene Therapy Strategy Meeting): Guadalupe presents about Internet of Things (IIoT) insights and knowledge to minimize waste within manufacturing systems.

MIT Latinx Keynote Banner.jpg

Keynote Speaker (MIT Latinx Graduation Keynote): Guadalupe celebrates the achievements of the Latinx Graduates.

Keynote Speaker (MIT Introduction to Technology, Engineering and Science): Guadalupe talks about his struggles with hemophilia in Mexico, , going to MIT, learning and finding purpose.

Webinar (New York City Hemophilia Chapter and New England Hemophilia Association): Guadalupe explores, in Spanish, advocacy in the Latino community and also about his life as a hemophiliac.

Contact

bottom of page